HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

455.580

-14.279-3.04%

Number of Gainers:2

Number of Losers:46

Number of Flat:3

PE:- -

High:467.950

Open:467.950

Low:449.431

Close:469.859

Volume:208.14M

Turnover:6.45B

Market Cap:2.92T

Float Cap:2.00T

Loading ...

Goldman Sachs Asset Management Underweight on Major Cloud Service Providers, Expects Continued Bond Issuance Wave

India Loosens Asset Management Rules: Portfolio Management Industry Permitted Overseas Investment and Stock Short-Selling for the First Time

Huihe Medical's STAR Market IPO Application Terminated; Company Focuses on Innovative Medical Devices in Panvascular Intervention

LifeTech Scientific's Stent Graft System Included in Chinese Regulators' Special Examination Procedure

MT Newswires Live

Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices

Hansoh Pharma's Application for Osteosarcoma Drug Accepted in China

MT Newswires Live

Lifetech Scientific Says Surechamtm Stent Graft Admitted to Nmpa Special Examination and Approval Procedure

LifeTech Scientific - Surechamtm Stent Graft Admitted to Nmpa Special Examination and Approval Procedure

THOMSON REUTERS

Hansoh Pharma's HS-20093 Osteosarcoma Marketing Application Accepted by China's NMPA

Hansoh Pharmaceutical - Biologics License Application of Risvutatug Rezetecan for Injection (Hs-20093) for Osteosarcoma Accepted by Nmpa

THOMSON REUTERS

Zheshang Asset Management Changes Leadership as 30-Year Securities Industry Veteran Takes the Helm

HYGEIA HEALTH Repurchases 143,200 Shares for HK$1.4 Million on September 24

China Resources Beer's Interim Report: Revenue Rises but Profit Falls as Baijiu Losses Widen and Goodwill Impairment Risk Persists

Antengene-B Spends HK$405,000 to Repurchase 117,500 Shares on September 24

ZYLOXTB (02190) Spends HK$1.1475 Million to Repurchase 54,500 Shares on September 24

Bioperfectus Secures Two Medical Device Registration Certificates

SUNAC SERVICES Repurchases 400,000 Shares for HK$303,700 on September 24

Ming Yuan Cloud Repurchases 500,000 Shares for HK$476,700 on September 24

AK Medical (01789) Spends About HK$211,400 to Repurchase 44,000 Shares on September 24

Maccura Biotechnology Secures Three Medical Device Registration Certificates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BK1583/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":455.5797,"timestamp":1790928487328,"preClose":469.8589,"halted":0,"volume":208138519,"delay":0,"changeRate":-0.03039,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-14.279175,"latestTime":"10-02 16:00:00","open":467.95047,"high":467.95047,"low":449.43094,"amount":6445271848,"amplitude":0.039415,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"pbRate":2.091824,"peRate":44.187873,"turnoverRate":0.001885,"increases":1,"decrements":46,"flats":2,"marketCap":2918312160368,"floatMarketCap":1999954498640},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":467.95047,"amplitude":0.039415,"preClose":469.8589,"low":449.43094,"pbRate":"2.091824","latestPrice":455.5797,"volume":208138519,"delay":0,"open":467.95047,"prevYearClose":503.90085,"prevWeekClose":459.069,"prevMonthClose":469.859,"prevQuarterClose":469.859,"fiveDayClose":459.726,"twentyDayClose":475.543,"sixtyDayClose":432.558,"secType":"PLATE","market":"HK","turnoverRate":0.001885,"peRate":44.187873,"marketCap":2918312160368,"floatMarketCap":1999954498640,"timestamp":1790928487328,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":2,"down":46,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174836986","title":"Goldman Sachs Asset Management Underweight on Major Cloud Service Providers, Expects Continued Bond Issuance Wave","url":"https://stock-news.laohu8.com/highlight/detail?id=1174836986","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174836986?lang=en_us&edition=fundamental","pubTime":"2026-09-25 07:50","pubTimestamp":1790293824,"startTime":"0","endTime":"0","summary":"Goldman Sachs Asset Management believes that as a large volume of new debt floods the market, the firm is currently underweight on the companies with the largest AI-related borrowing, and expects...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1258","BK4516","LU2237443978.SGD","LU1894683264.USD","BK4552","BK4585","IE00B19Z3581.USD","LU2237443465.HKD","LU2750360997.AUD","LU0868494708.USD","LU2237438978.USD","BK1229","BK1583","LU0345770993.USD","LU1894683348.USD","LU0251131958.USD","LU1668664300.SGD","LU2237443382.USD","LU2471134796.USD","LU2896262040.SGD","AMGR","IE0034235188.USD","GS","BK4588","IE0002270589.USD","LU1868836591.USD","LU1868836914.USD","LU0345770308.USD","LU0742534661.SGD","LU1868837300.USD","LU2471134523.USD","LU2750360641.GBP","GABF","LU1144417596.USD","LU2265009873.SGD","LU0210536198.USD","LU0061475181.USD","GSX","IE0004086264.USD","IE0004091025.USD","LU2237443549.SGD","09983","BK4504","ADVX","LU1868836757.USD","LU0106831901.USD","BK4550","LU2471134952.CNY","LU1868837136.USD","BK4533","LU0868494617.USD","TRUF","IE00B19Z3B42.SGD","LU0048573561.USD","LU2237443622.USD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU1804176565.USD","LU2471134879.HKD","LU0942090050.USD","BK4127","PFI","LU1791807156.HKD","LU0251142724.SGD","LU2237443895.HKD","BK1542","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182463417","title":"India Loosens Asset Management Rules: Portfolio Management Industry Permitted Overseas Investment and Stock Short-Selling for the First Time","url":"https://stock-news.laohu8.com/highlight/detail?id=1182463417","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182463417?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:08","pubTimestamp":1790284096,"startTime":"0","endTime":"0","summary":"India's securities market is undergoing significant reform.India's market regulator announced on Thursday that it will allow the $463 billion portfolio management services (PMS) industry to invest in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","MNDmain","BK1542","GABF","AMGR","BK1258","09983","PFI","TRUF","ADVX","BK1229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193610255","title":"Huihe Medical's STAR Market IPO Application Terminated; Company Focuses on Innovative Medical Devices in Panvascular Intervention","url":"https://stock-news.laohu8.com/highlight/detail?id=1193610255","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193610255?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:54","pubTimestamp":1790254489,"startTime":"0","endTime":"0","summary":"Huihe Medical's STAR Market IPO review status was changed to \"terminated\" on September 24, as the company and its sponsor withdrew the listing application, according to the relevant provisions of the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REDS","BK1100","GDOC","MDEV","IPOS","KCE","AGNG","LNGR","09996","159883","RSPH","LGHT","BK1583","BK4127","159891","MEDX","HART","KSTR","BK1574","PTH","FRHC","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669498202","title":"LifeTech Scientific's Stent Graft System Included in Chinese Regulators' Special Examination Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669498202","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669498202?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:49","pubTimestamp":1790254143,"startTime":"0","endTime":"0","summary":"LifeTech Scientific's  SureCham Aortic Arch Single-Branch Stent Graft System was admitted into the special examination and approval procedure for innovative medical devices by China's National Medical Products Administration.The device was co-developed with Shu Chang's team at Fuwai Hospital, the Chinese Academy of Medical Sciences of the National Center for Cardiovascular Diseases, a Thursday bourse filing showed.The product is indicated for the treatment of aortic dissection involving the aortic arch.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1100","BK1600","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104658454","title":"Lifetech Scientific's SureCham Aortic Arch Single-Branch Stent Graft System Enters Special Review Pathway for Innovative Medical Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1104658454","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104658454?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:16","pubTimestamp":1790252179,"startTime":"0","endTime":"0","summary":"Lifetech Scientific (01302) has announced that on September 24, 2026, the company received formal written notification from the National Medical Products Administration confirming that the SureCham...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1583","HART","LNGR","RSPH","IEIH","PTH","BK1100","BK1600","MDEV","BK1574","MEDX","GDOC","159883","AGNG","LGHT","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669206460","title":"Hansoh Pharma's Application for Osteosarcoma Drug Accepted in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2669206460","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669206460?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:15","pubTimestamp":1790252104,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical's  biologics license application for HS-20093 for injection was accepted by China's National Medical Products Administration.The acceptance is for the treatment of osteosarcoma patients 12 years of age and above who have failed at least two prior lines of therapy, a Thursday bourse filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["03692","BK1191","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669546048","title":"Lifetech Scientific Says Surechamtm Stent Graft Admitted to Nmpa Special Examination and Approval Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669546048","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669546048?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:10","pubTimestamp":1790251835,"startTime":"0","endTime":"0","summary":"Sept 24 (Reuters) - LifeTech Scientific Corp <1302.HK>::*SURECHAMTM STENT GRAFT ADMITTED TO NMPA SPECIAL EXAMINATION AND APPROVAL PROCEDURE*Further company coverage: 1302.HK* ((reuters.briefs@thomsonr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nRSD8rhpj1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","01302","BK1600","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460835","title":"LifeTech Scientific - Surechamtm Stent Graft Admitted to Nmpa Special Examination and Approval Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460835","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460835?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:57","pubTimestamp":1790251057,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0DD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01302","BK1583","BK1600","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125705969","title":"Hansoh Pharma's HS-20093 Osteosarcoma Marketing Application Accepted by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1125705969","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125705969?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:38","pubTimestamp":1790249902,"startTime":"0","endTime":"0","summary":"On September 24, 2026, Hansoh Pharma (03692) announced that the marketing application for its innovative drug, HS-20093 for injection (recombinant anti-B7-H3 antibody-drug conjugate), has been...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IPOS","BK1191","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669546769","title":"Hansoh Pharmaceutical - Biologics License Application of Risvutatug Rezetecan for Injection (Hs-20093) for Osteosarcoma Accepted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2669546769","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669546769?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:30","pubTimestamp":1790249459,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1191","03692","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123064179","title":"Zheshang Asset Management Changes Leadership as 30-Year Securities Industry Veteran Takes the Helm","url":"https://stock-news.laohu8.com/highlight/detail?id=1123064179","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123064179?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:26","pubTimestamp":1790249198,"startTime":"0","endTime":"0","summary":"On September 24, Zhejiang Zheshang Securities Asset Management Co., Ltd. (hereinafter referred to as \"Zheshang Asset Management\") issued an \"Announcement on Changes of Senior Management Personnel.\"...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADVX","GABF","BK1229","TRUF","KCE","09983","BK1258","PFI","AMGR","BK1583","BK1542"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109900716","title":"HYGEIA HEALTH Repurchases 143,200 Shares for HK$1.4 Million on September 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1109900716","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109900716?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:20","pubTimestamp":1790245220,"startTime":"0","endTime":"0","summary":"HYGEIA HEALTH (06078) announced that on September 24, 2026, the company spent HK$1.4 million to repurchase 143,200 shares.The repurchase price per share ranged from HK$9.765 to HK$9.78.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","LU0737861772.HKD","BK1583","LU0329678337.USD","06078","LU2488822045.USD","LU0329678170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110730844","title":"China Resources Beer's Interim Report: Revenue Rises but Profit Falls as Baijiu Losses Widen and Goodwill Impairment Risk Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=1110730844","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110730844?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:51","pubTimestamp":1790243499,"startTime":"0","endTime":"0","summary":"Against the backdrop of an overall contraction in the industry, beer companies have begun a major reshuffle. According to data from the National Bureau of Statistics, from January to June 2026, beer...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00291","IE0008368742.USD","IE00B031HY20.USD","LU1720050803.USD","BK1604","BK1578","CRHKY","IE0008369823.USD","BK1583","IE00B29SXG58.USD","IE00B543WZ88.USD","LU1023057109.AUD","LU0359202008.SGD","IE00B5MMRT66.SGD","ITAN","LU1769817096.USD","BK1570","IE00B0169L03.USD","80291","BK1589","LU0328353924.USD","IE00BPRC5H50.USD","BK1180","LU1769817179.HKD","IE0031814852.USD","LU1794554557.SGD","SG9999006514.SGD","LU1328615791.USD","LU0359201612.USD","BK1521","BK1510"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153379729","title":"Antengene-B Spends HK$405,000 to Repurchase 117,500 Shares on September 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1153379729","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153379729?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:44","pubTimestamp":1790243061,"startTime":"0","endTime":"0","summary":"Antengene-B (06996) announced that on September 24, 2026, the company spent HK$405,000 to repurchase 117,500 shares, at a repurchase price of HK$3.405 to HK$3.58 per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996","BK1191","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105116259","title":"ZYLOXTB (02190) Spends HK$1.1475 Million to Repurchase 54,500 Shares on September 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1105116259","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105116259?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:30","pubTimestamp":1790242259,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) announced that the company repurchased 54,500 shares on September 24, 2026, for a total consideration of HK$1.1475 million, at a repurchase price ranging from HK$20.74 to HK$21.3 per...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1100","02190","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131609096","title":"Bioperfectus Secures Two Medical Device Registration Certificates","url":"https://stock-news.laohu8.com/highlight/detail?id=1131609096","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131609096?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:20","pubTimestamp":1790241617,"startTime":"0","endTime":"0","summary":"Bioperfectus Technologies (688399.SH) announced that it has recently received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","688399","HART","LNGR","RSPH","IEIH","PTH","BK1100","MDEV","BK1574","MEDX","GDOC","159883","AGNG","LGHT","09996","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195383124","title":"SUNAC SERVICES Repurchases 400,000 Shares for HK$303,700 on September 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1195383124","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195383124?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:20","pubTimestamp":1790241616,"startTime":"0","endTime":"0","summary":"SUNAC SERVICES (01516) has announced that on September 24, 2026, it repurchased 400,000 shares at a total cost of HK$303,700.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01516","BK1585","BK1542","BK1583","BK1229","BK1258"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188528540","title":"Ming Yuan Cloud Repurchases 500,000 Shares for HK$476,700 on September 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1188528540","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188528540?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:16","pubTimestamp":1790241385,"startTime":"0","endTime":"0","summary":"Ming Yuan Cloud (00909) announced that on September 24, 2026, it repurchased 500,000 shares for HK$476,700.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1117","BK1589","BK1607","BK1618","BK1583","00909","BK1518","BK1109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104034625","title":"AK Medical (01789) Spends About HK$211,400 to Repurchase 44,000 Shares on September 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1104034625","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104034625?lang=en_us&edition=fundamental","pubTime":"2026-09-24 17:06","pubTimestamp":1790240793,"startTime":"0","endTime":"0","summary":"AK Medical (01789) announced that on September 24, 2026, the company spent approximately HK$211,400 to repurchase 44,000 shares at a price of HK$4.805 per share.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","01789","BK1617","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198667592","title":"Maccura Biotechnology Secures Three Medical Device Registration Certificates","url":"https://stock-news.laohu8.com/highlight/detail?id=1198667592","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198667592?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:59","pubTimestamp":1790240378,"startTime":"0","endTime":"0","summary":"Maccura Biotechnology Co.,Ltd. (300463.SZ) has announced that the company recently received three Medical Device Registration Certificates issued by the Sichuan Provincial Medical Products...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","HART","IEIH","300463","MEDX","BK1583","LNGR","AGNG","BK0046","PTH","LGHT","RSPH","159883","BK0012","BK1100","MDEV","09996","GDOC","BK0028","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":8,"totalSize":242,"code":"91000000","status":"200"}]}}